$MSC Cashflow Statement | Understand Stock

$MSC

$0.79 +$0.02 (2.88%) Close

$MSC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization
Amortization of deferred financing costs and original issue premiums
Loss on disposal of property and equipment and other long-term assets
Impairment of property and equipment
Write-off of other assets
Provision for (reversal of) credit losses
Loss (gain) on extinguishment of debt
Costs associated with debt modification

Changes in operating assets and liabilities:
Accounts receivable
Receivables from affiliated companies
Inventories, prepaid expenses and other
Long-term prepayments, deposits and other
Accounts payable, accrued expenses and other
Payables to affiliated companies
Other long-term liabilities
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Acquisition of property and equipment
Payments to an affiliated company for other long-term assets
Proceeds from sale of property and equipment
Funds to an affiliated company
Placement of bank deposits with original maturities over three months
Acquisition of intangible assets
Withdrawals of bank deposits with original maturities over three months
Net cash used in investing activities
Cash flows from financing activities:
Repayments of long-term debt
Proceeds from long-term debt
Payments of financing costs
Net proceeds from issuance of shares
Net cash used in financing activities
Effect of exchange rate on cash, cash equivalents and restricted cash
Decrease in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Supplemental cash flow disclosures:
Cash paid for interest, net of amounts capitalized
Cash paid for amounts included in the measurement of lease liabilities - operating cash flows from operating leases
Repayments of long-term debt to a director of SCIH
Proceeds on sale of property and equipment from affiliated companies
Non-cash disclosures:
Change in operating lease right-of-use assets and lease liabilities arising from lease modification
Change in accrued expenses and other current liabilities related to acquisition of property and equipment
Change in amounts due from/to affiliated companies related to acquisition of property and equipment and other long-term assets
Change in amounts due to affiliated companies related to acquisition of intangible assets
Change in payables to affiliated companies related to acquisition of intangible assets
Offering expenses capitalized for the issuance of shares included in accrued expenses and other current liabilities
Change in payables to affiliated companies related to acquisition of property and equipment
Change in accrued expenses and other current liabilities related to financing costs
Transfer of property and equipment to assets under sales-type lease and included in prepaid expenses and other current assets and long-term prepayments, deposits and other assets

Comments